Showing posts with label ovarian cancer symptoms. Show all posts
Showing posts with label ovarian cancer symptoms. Show all posts
Tuesday, April 24, 2012
Campaigners call for Scottish Government to act over needless ovarian cancer deaths - The Daily Record
Campaigners call for Scottish Government to act over needless ovarian cancer deaths - The Daily Record
"New research shows woeful symptom awareness among women in Scotland with only one per cent of those surveyed being very confident of noticing a symptom. Across the UK the figure was just three per cent.
And, of the GPs surveyed in Scotland, 86 per cent agreed that updates to Scottish clinical guidelines would support them to diagnose ovarian cancer more effectively.
Now campaigners have called on the Scottish Government top spearhead a national campaign to increase symptom awareness.
In April 2011, the National Institute for Health and Clinical Excellence (NICE) published the first official guidance to GPs in England and Wales about the symptoms, diagnosis and early treatments for ovarian cancer.
The Target Ovarian Cancer Pathfinder Study 2012 found 68 per cent of a UK-wide representative sample of 402 GPs was aware of the NICE guidance.
However, GPs in Scotland will have to wait until later this year for updated guidance from the Scottish Intercollegiate Guidelines Network......"
Target Ovarian Cancer can be found online at www.targetovariancancer.org.uk
Tuesday, April 03, 2012
Friday, March 16, 2012
Saturday, March 03, 2012
UK media: Charity calls for ovarian cancer awareness campaign (one percent aware of ovarian cancer symptoms)
"ONLY one per cent of women in the East of England are very confident in noticing symptoms of ovarian cancer, and a leading charity says symptom awareness could prevent needless deaths.....".
"The Target Ovarian Cancer Pathfinder Study 2012 did find the number of women who recognised bloating as a major sympton has nearly doubled from nine per cent to 17 per cent, but in the East of England this was 13 per cent.
The charity said this still compares poorly to other cancers with 76 per cent of women knowing a breast lump is a sign of breast cancer.
Ms Jones said: “The evidence is piling up. Women are being let down by the failure to act in the UK. We need a national awareness campaign now to end needless deaths from this disease......"
Monday, January 16, 2012
Saturday, January 14, 2012
abstract: Predictive Value of Symptoms for Ovarian Cancer: Comparison of Symptoms Reported by Questionnaire, Interview, and General Practitioner Notes
Background:Because of the poor survival outcomes associated with advanced ovarian cancer, early detection strategies are needed. Although several symptom indices have been described, their relationship with the potential lead time has been poorly documented.
Methods
Women aged 50–79 years who had newly diagnosed ovarian cancer (n = 194) and control subjects (n = 268) who attended ovarian cancer screening clinics were included in the analysis.
Conclusions
Previous estimates of index performance have been overly optimistic because they did not take into account the time required to make a diagnosis on the basis of testing in response to symptoms. In addition, the specificity of a symptom index is lower when based on a telephone interview vs questionnaire or GP notes. Thus, the clinical utility of a symptom index depends on precisely how it is used and how index-positive women are managed.
Monday, June 28, 2010
abstract: Prevalence of bowel symptoms in women with pelvic floor disorders
Conclusions
"Women rarely seek urogynecologic care primarily for bowel symptoms, although they have a high prevalence of bowel symptoms."
Thursday, June 24, 2010
Update on Paraneoplastic Neurologic Disorders
Note: very complicated condition/conditions/subsets of conditions and requires specialist consultation/s.
"When patients with cancer develop neurologic symptoms, common causes include metastasis, infections, coagulopathy, metabolic or nutritional disturbances, and neurotoxicity from treatments. A thorough clinical history, temporal association with cancer therapies, and results of ancillary tests usually reveal one of these mechanisms as the etiology. When no etiology is identified, the diagnosis considered is often that of a paraneoplastic neurologic disorder (PND). With the recognition that PNDs are more frequent than previously thought, the availability of diagnostic tests, and the fact that, for some PNDs, treatment helps, PNDs should no longer be considered diagnostic zebras, and when appropriate should be included in the differential diagnosis early in the evaluation."
Thursday, June 03, 2010
It's a choice to move forward: women's perceptions about treatment decision making in recurrent ovarian cancer
Abstract
OBJECTIVE: This research explores the treatment decision-making (TDM) experiences of women with recurrent ovarian cancer (ROC) with regard to treatment options; their understanding of risks and benefits of various treatment options; the decision-making role they want for themselves and for their oncologist; and the social context of the consultation as it pertains to the decision.
METHODS: We conducted semi-structured interviews with 26 women at the time of first recurrence. Through inductive data analysis key themes were identified.
RESULTS: Many women describe self-identifying the cancer recurrence fairly quickly due to new symptoms. Many feel that the goal for treating their recurrence is to control versus cure the cancer. They describe the subsequent process of diagnosis and TDM for ROC as quick and straightforward with all women accepting the oncologists' treatment recommendation. They feel that the type and number of treatment options are limited. They have a strong desire for physician continuity in their care. Participants feel that their doctor's recommendations as well as their previous experience with ovarian cancer are strong factors influencing their current TDM process.
CONCLUSIONS: Shared decision making is based on a simultaneous participation of both the physician and patient in TDM. When faced with ROC, women feel that their doctor's recommendation and their past experience with treatment and TDM are prominent factors influencing the current TDM process.
Wednesday, February 17, 2010
Identification of Ovarian Cancer Symptoms in Health Insurance Claims Data
Conclusions:
"These results support previous findings that ovarian cancer symptoms were reported in health insurance claims and were more prevalent before diagnosis, but the symptoms may occur too close to the diagnosis date to provide useful diagnostic information. The passive screening approach should be reevaluated in the future using electronic medical records; if found to be effective, the method may be potentially useful for other incident diseases."
Monday, February 01, 2010
Sunday, January 31, 2010
Friday, January 29, 2010
Tuesday, December 01, 2009
Subscribe to:
Posts
(
Atom
)
